Pfizer to begin manufacturing Covid-19 vaccine components in Ireland by end of the year

Ireland will begin to produce key Covid-19 vaccine components later this year, with Pfizer announcing that they will be investing in their west Dublin plant. The pharmaceutical giant made the announcement today, saying that they would be investing $40 million in upgrading their Grange Castle plant. In a statement, Pfizer said that they have made several enhancements to the vaccine supply chain since they began rolling out their mRNA vaccine in late December. “As such, Pfizer is now bringing on additional European-based facility to be a part of the global Pfizer-BioNTech COVID-19 Vaccine supply chain network and Grange Castle (Ireland) will contribute to the worldwide supply of the vaccine,” they said in a statement.